Clinical experience of treating Graves’ hyperthyroidism complicated with malignancy—The possible role of potassium iodide for avoiding the risk of thionamide-associated neutropenia
Author:
Affiliation:
1. Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan
Publisher
Japan Endocrine Society
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
https://www.jstage.jst.go.jp/article/endocrj/67/7/67_EJ20-0016/_pdf
Reference34 articles.
1. 1 Hartmann K (2015) Thyroid disorders in the oncology patient. J Adv Pract Oncol 6: 99–106.
2. 2 Barroso-Sousa R, Ott PA, Hodi FS, Kaiser UB, Tolaney SM, et al. (2018) Endocrine dysfunction induced by immune checkpoint inhibitors: practical recommendations for diagnosis and clinical management. Cancer 124: 1111–1121.
3. 3 Azmat U, Liebner D, Joehlin-Price A, Agrawal A, Nabhan F (2016) Treatment of ipilimumab induced Graves’ disease in a patient with metastatic melanoma. Case Rep Endocrinol 2016: 2087525.
4. 4 Min L, Vaidya A, Becker C (2011) Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapy. Eur J Endocrinol 164: 303–307.
5. 5 Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, et al. (2016) 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26: 1343–1421.
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Evaluation and Management of Methimazole-Induced Agranulocytosis in the Pediatric Patient: A Case Report and Review of the Literature;Hormone Research in Paediatrics;2024-01-31
2. Application of oral inorganic iodine in the treatment of Graves’ disease;Frontiers in Endocrinology;2023-04-03
3. Iodide-sensitive Graves’ hyperthyroidism and the strategy for resistant or escaped patients during potassium iodide treatment;Endocrine Journal;2022
4. Antineoplastics/potassium iodide/thiamazole;Reactions Weekly;2020-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3